Specialty code 1835P0018X · Sacramento, CA
NPI
1134722648
Since 2020
Specialty
Specialty code 1835P0018X
Code 1835P0018X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
7880 Alta Valley Dr
Sacramento, CA, 95823
Phone (555) 555-5555
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$513K
3,606 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Jackie Huang prescribed most often to Medicare patients was Atorvastatin Calcium, with 512 prescriptions and refills. In total Jackie Huang wrote 3,606 Medicare prescriptions that cost $513K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-19.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 512 | 1,701 | 209 | $6,181 |
| Metformin Hcl Er Metformin Hcl | 327 | 1,073 | 139 | $3,218 |
| Metformin Hcl Generic | 314 | 1,038 | 122 | $4,245 |
| Glipizide Generic | 256 | 834 | 103 | $3,134 |
| Jardiance Empagliflozin | 190 | 588 | 74 | $103K |
| Humulin N Insulin Nph Human Isophane | 180 | 538 | 82 | $36K |
| Lisinopril Generic | 159 | 529 | 68 | $1,904 |
| Ozempic Semaglutide | 137 | 144 | 22 | $107K |
| Victoza 2-Pak Liraglutide | 133 | 133 | 30 | $85K |
| Glipizide Er Glipizide | 118 | 383 | 52 | $3,874 |
| Amlodipine Besylate Generic | 117 | 362 | 52 | $1,509 |
| Losartan Potassium Generic | 101 | 336 | 46 | $1,282 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 93 | 271 | 38 | $1,831 |
| Insulin Glargine-Yfgn Generic | 93 | 273 | 60 | $17K |
| Simvastatin Generic | 90 | 300 | 36 | $1,050 |
Brand drugs: 1,028 claims; generic drugs: 2,319 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jackie Huang were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.